Viewing Study NCT01485835


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-02-02 @ 11:47 AM
Study NCT ID: NCT01485835
Status: COMPLETED
Last Update Posted: 2015-10-12
First Post: 2011-12-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma
Sponsor: Emory University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None Bortezomib View
None Velcade View
None Ganetespib View